Literature DB >> 9585059

Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters.

M Koyuncuoğlu1, A Kargi, S Cingöz, Z Kirkali.   

Abstract

The association between known prognostic variables such as TNM stage, histological grade and mutant p53 tumor suppressor gene product, c-erbB-2 oncoprotein, DNA ploidy and cell kinetic data, including mitoses, PCNA expression, AgNOR scores and apoptosis, was investigated in 29 transitional cell carcinoma (TCC) cases. A positive correlation between the histologic grade and all the studied parameters, except for c-erbB-2 expression, and a positive correlation between the stage and histological grade, DNA ploidy, mitoses, apoptosis and p53 expression were found. The results of this study are in accordance with some of the previous studies, except for apoptosis which had been studied for the first time in TCCs. Although we found a statistically significant correlation between the apoptosis and both tumor stage and histological grade, the predictive value of apoptosis as an independent prognostic factor remains to be established in a larger series.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585059     DOI: 10.1016/s0304-3835(97)00532-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  AgNOR/P53 expression compared with different grades in bladder carcinoma.

Authors:  M Karakök; A Aydin; K Bakir; R Uçak; C Korkmaz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.

Authors:  Murat Bozlu; Diclehan Orhan; Sümer Baltaci; Onder Yaman; Atilla Halil Elhan; Ozden Tulunay; Yusuf Ziya Müftüoğlu
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c-erbb-2) status in urothelial carcinoma.

Authors:  Gonzague de Pinieux; Delphine Colin; Anne Vincent-Salomon; Jérôme Couturier; Delphine Amsellem-Ouazana; Philippe Beuzeboc; Annick Vieillefond
Journal:  Virchows Arch       Date:  2004-03-17       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.